[go: up one dir, main page]

AU1575383A - 1,4-dihyropyridine derivatives - Google Patents

1,4-dihyropyridine derivatives

Info

Publication number
AU1575383A
AU1575383A AU15753/83A AU1575383A AU1575383A AU 1575383 A AU1575383 A AU 1575383A AU 15753/83 A AU15753/83 A AU 15753/83A AU 1575383 A AU1575383 A AU 1575383A AU 1575383 A AU1575383 A AU 1575383A
Authority
AU
Australia
Prior art keywords
dihyropyridine
derivatives
dihyropyridine derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU15753/83A
Other languages
English (en)
Inventor
Arnold Vogel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU1575383A publication Critical patent/AU1575383A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D271/00Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/12Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AU15753/83A 1982-06-15 1983-06-14 1,4-dihyropyridine derivatives Abandoned AU1575383A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH369382 1982-06-15
CH369382 1982-06-15
CH369282 1982-06-15
CH369282 1982-06-15

Publications (1)

Publication Number Publication Date
AU1575383A true AU1575383A (en) 1983-12-22

Family

ID=25693638

Family Applications (1)

Application Number Title Priority Date Filing Date
AU15753/83A Abandoned AU1575383A (en) 1982-06-15 1983-06-14 1,4-dihyropyridine derivatives

Country Status (19)

Country Link
AU (1) AU1575383A (es)
BE (1) BE897000A (es)
CA (1) CA1208639A (es)
CH (1) CH660593A5 (es)
DE (1) DE3320616A1 (es)
DK (1) DK271183A (es)
ES (2) ES8504179A1 (es)
FI (1) FI832072L (es)
FR (1) FR2528431B1 (es)
GB (1) GB2122192B (es)
HU (1) HU191853B (es)
IT (1) IT1178353B (es)
NL (1) NL8302067A (es)
NZ (1) NZ204536A (es)
PH (1) PH23436A (es)
PT (1) PT76870B (es)
SE (1) SE8303385L (es)
WO (1) WO1984000033A1 (es)
ZA (1) ZA834409B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3431152A1 (de) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel
US5260321A (en) * 1984-11-12 1993-11-09 Sandoz Ltd. Use of 1,4-dihydropyridine derivatives and combinations thereof with calcitonins
GB8428552D0 (en) * 1984-11-12 1984-12-19 Sandoz Ltd Organic compounds
DE3447169A1 (de) * 1984-12-22 1986-07-03 Bayer Ag, 5090 Leverkusen Optisch aktive nitrodihydropyridine, verfahren zur herstellung und ihre verwendung in arzneimitteln
US4920225A (en) * 1986-12-22 1990-04-24 Laboratoires Syntex S.A. Resolution of 1,4-dihydropyridine derivatives
EP0287828A1 (de) * 1987-03-27 1988-10-26 Byk Gulden Lomberg Chemische Fabrik GmbH Neue Zwischenprodukte und Verfahren
DE4041814A1 (de) * 1990-12-24 1992-07-02 Byk Gulden Lomberg Chem Fab Verfahren zur herstellung von dihydrophyridincarbonsaeuren
US5135936A (en) * 1991-03-05 1992-08-04 Marion Merrell Dow Inc. Isomers of 1-azabicyclo[2.2.2]oct-3-yl methyl 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinediacarboxylic and their use as calcium antagonists
CN100425599C (zh) * 2005-12-31 2008-10-15 清华大学 一种有机电致发光材料及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
FI64938C (fi) * 1977-06-20 1984-02-10 Sandoz Ag Foerfarande foer framstaellning av nya terapeutiskt anvaendbara bensoxa- och bensotiadiazolyl-1,4-dihydropyridinderivat
DE2949464A1 (de) * 1978-12-18 1980-06-26 Sandoz Ag Benzoxadiazole und benzothiadiazole, ihre herstellung und verwendung
FI813460L (fi) * 1980-11-10 1982-05-11 Sandoz Ag Nya 4-(2,1,3-benzoxadiazol-4-yl)-1,4-dihydro-pyridinderivat deras framstaellningsfoerfarande och dessa innehaollande farmaceutiska kompositioner

Also Published As

Publication number Publication date
PT76870B (en) 1986-02-27
NL8302067A (nl) 1984-01-02
FI832072A7 (fi) 1983-12-16
PT76870A (en) 1983-07-01
CH660593A5 (de) 1987-05-15
NZ204536A (en) 1986-09-10
HU191853B (en) 1987-04-28
IT8348488A0 (it) 1983-06-13
DK271183A (da) 1983-12-16
ES538157A0 (es) 1986-02-01
WO1984000033A1 (fr) 1984-01-05
DK271183D0 (da) 1983-06-13
GB8316054D0 (en) 1983-07-20
BE897000A (fr) 1983-12-09
ES8604578A1 (es) 1986-02-01
ES523243A0 (es) 1985-04-01
SE8303385D0 (sv) 1983-06-14
PH23436A (en) 1989-08-07
SE8303385L (sv) 1983-12-16
FI832072L (fi) 1983-12-16
FR2528431B1 (fr) 1986-01-10
GB2122192A (en) 1984-01-11
ES8504179A1 (es) 1985-04-01
IT1178353B (it) 1987-09-09
DE3320616A1 (de) 1983-12-15
FR2528431A1 (fr) 1983-12-16
CA1208639A (en) 1986-07-29
GB2122192B (en) 1985-12-18
FI832072A0 (fi) 1983-06-08
ZA834409B (en) 1985-02-27

Similar Documents

Publication Publication Date Title
AU570667B2 (en) 2-phenyl-3-oxo-3,4-dihydro-benzothiazine(1,4) derivatives
AU7338081A (en) 1,2,4-triazolylpropenol derivatives
AU563950B2 (en) 2,2 -disubstituted-1,3-oxepine derivatives
AU1792983A (en) 2,3-dihydrobenzofurans
AU2956484A (en) Benzoxadiazol-4-yl-1,4 dibyropyridine derivatives
AU1575383A (en) 1,4-dihyropyridine derivatives
AU1666583A (en) 1,2,5-thiadiazole derivatives
AU2435784A (en) 8,10-dideazaminopterins
AU2599884A (en) 1,8-dihydroxy-10-acyl-9-anthrones
AU8413382A (en) 1,4-piperizine derivatives
GB8301383D0 (en) 3,3-dialkyl-and 3,3-alkylene-indoline derivatives
AU572878B2 (en) 3,6-dihydro-3-methyl-6-oxo-pyran-2-yl derivative
AU568295B2 (en) 1,2,4-triazol-i-yl-propionitrile derivatives
AU557580B2 (en) 15-cycloaliphatic derivatives of 13,14-didehydro- carboprostacyclins
AU1448083A (en) 1,3-dioxolan-2-yl-methyl-imidazole/1,2,4-triazole derivatives
AU1741583A (en) 1,4-benzothiazine derivatives
AU551883B2 (en) 2,5-bis-perfluoroalkyl-3,4-dicarbonylalkoxypyrroles
AU1176983A (en) 2,3-dihydro-1h-pyrrolizines
AU8879882A (en) 1,2,3-thiadiazol-5-yl-urea derivatives
AU572869B2 (en) 1,6-naphthyridin derivatives
AU636164B2 (en) 2,3-dihydro-1-hydroxy-3-oxo-2-(1-substituted-4-piperidinyl)- 1N-isoindole derivatives
AU3339584A (en) 1,2,4-triazolylmethyl - pyridyloxymethyl - carbinol derivatives
AU7744681A (en) 2,3-dihydro-4-pyrone derivatives
AU8879782A (en) 1,2,3-thiadiazol-5-yl-urea derivatives
AU1180383A (en) 1,2,4-triazole derivatives